HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process

被引:18
作者
Dousa, Michal [1 ]
Klvana, Robert [1 ]
Doubsky, Jan [1 ]
Srbek, Jan [1 ]
Richter, Jindrich [1 ]
Exner, Marek [2 ]
Gibala, Petr [1 ]
机构
[1] Zentiva Ks, U Kabelovny 130, Prague 10237 10, Czech Republic
[2] Waters Gesell MbH, Psohlavcu 43, Prague 14700 4, Czech Republic
关键词
LU AA21004; DERIVATIZATION; AGENTS; ASSAY; ALKYL;
D O I
10.1093/chromsci/bmv107
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the last decade, pharmaceutical regulatory agencies are focused on monitoring and evaluation of trace-level genotoxic impurities (GTIs) in drug substances, which requires manufacturers to deliver innovative approaches for their analysis and control. GTIs in the low p.p.m. level rising from the process of drug production have to be positively identified and quantified. Therefore, sensitive and selective analytical methods are necessary for required quantification level of these GTIs. Unfortunately, general guidance on how to develop strategy of the analysis and control of GTIs is currently missing in the pharmaceutical industry. Therefore, practical example of the analytical control of 2-chloro-N-(2-chloroethyl)ethanamine GTI in the vortioxetine (VOR) manufacturing process was demonstrated in this work. QDa mass detection with electrospray ionization in selected-ion recording mode was utilized for quantitation of GTIs. The method of hydrophilic interaction liquid chromatography coupled with mass spectrometry detection (HILIC-MS) was validated as per International Conference on Harmonization guidelines and was able to quantitate GTIs at 75 p.p.m. with respect to VOR. The HILIC-MS method was achieved using a Primesep B column (150 x 4.6mm, 5.0 mu m; Sielc, USA) using mobile phase consisting of 10 mM ammonium formate buffer pH 3.0 and acetonitrile (5 : 95, v/v) at 0.8 mL/min flow rate. The QDa mass detector was operated in the positive ion mode. Quadrupole mass analyzer was employed in selected-ion monitoring mode using target ion at m/z 142 as [M+H](+).
引用
收藏
页码:119 / 124
页数:6
相关论文
共 30 条
  • [1] A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances
    An, Jianguo
    Sun, Mingjiang
    Bai, Lin
    Chen, Ted
    Liu, David Q.
    Kord, Alireza
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (03) : 1006 - 1010
  • [2] [Anonymous], 2009, EUR PHARM, P4407
  • [3] [Anonymous], 2013, ICH M7 ASS CONTR DNA
  • [4] [Anonymous], 2006, IMPURITIES NEW DRUG
  • [5] [Anonymous], [No title captured], Patent No. [WO 2014/161976 A1, 2014161976]
  • [6] [Anonymous], 2014, [No title captured], Patent No. [CN 103788019 A - 2014-05-14, 103788019]
  • [7] [Anonymous], 2005, INT C HARM VAL AN PR
  • [8] Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API)
    Borman, Phil J.
    Chatfield, Marion J.
    Crowley, Elizabeth L.
    Eckers, Christine
    Elder, David P.
    Francey, Scott W.
    Laures, Alice M. -F.
    Wolff, Jean-Claude
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (04) : 1082 - 1089
  • [9] Evaluation of a compact mass spectrometer for routine support of pharmaceutical chemistry
    Bu, Xiaodong
    Yang, Jiong
    Gong, Xiaoyi
    Welch, Christopher J.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 94 : 139 - 144
  • [10] Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
    Chen, Grace
    Lee, Ronald
    Hojer, Astrid-Maria
    Buchbjerg, Jeppe Klint
    Serenko, Michael
    Zhao, Zhen
    [J]. CLINICAL DRUG INVESTIGATION, 2013, 33 (10) : 727 - 736